Induction and maintenance therapy of lupus nephritis: an obituary

Kidney Int. 2021 Feb;99(2):288-291. doi: 10.1016/j.kint.2020.11.009.

Authors

Hans-Joachim Anders¹, Yutian Lei², Brad H Rovin³

Affiliations

¹ Renal Division, Department of Medicine IV, University Hospital of the Ludwig Maximilian University, Munich, Germany. Electronic address: hjanders@med.uni-muenchen.de.
² Renal Division, Department of Medicine IV, University Hospital of the Ludwig Maximilian University, Munich, Germany.
³ Division of Nephrology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

PMID: 33509346
DOI: 10.1016/j.kint.2020.11.009

No abstract available

Keywords: inflammation; lupus nephritis; proteinuria; treatment.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immunosuppressive Agents / adverse effects
Lupus Nephritis* / drug therapy
Mycophenolic Acid
Proteinuria
Treatment Outcome

Substances

Immunosuppressive Agents
Mycophenolic Acid

Grants and funding

R01 AR071947/AR/NIAMS NIH HHS/United States